Bellevue Group’s AbbVie ABBV Stock Holding History

Bellevue Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$29.6M	Buy	159,661 +24,421	+18%	+$4.53M	0.65%	39
2025 Q1	$28.3M	Buy	135,240 +89,981	+199%	+$18.9M	0.63%	37
2024 Q4	$8.04M	Buy	45,259 +2,373	+6%	+$422K	0.15%	84
2024 Q3	$8.47M	Buy	42,886 +682	+2%	+$135K	0.14%	89
2024 Q2	$7.24M	Buy	42,204 +14,611	+53%	+$2.51M	0.12%	92
2024 Q1	$5.02M	Buy	27,593 +20,866	+310%	+$3.8M	0.08%	97
2023 Q4	$1.04M	Buy	6,727 +1,964	+41%	+$304K	0.02%	119
2023 Q3	$710K	Sell	4,763 -1,411	-23%	-$210K	0.01%	138
2023 Q2	$832K	Sell	6,174 -11,002	-64%	-$1.48M	0.01%	133
2023 Q1	$2.74M	Buy	17,176 +976	+6%	+$156K	0.04%	112
2022 Q4	$2.62M	Sell	16,200 -797	-5%	-$129K	0.03%	121
2022 Q3	$2.28M	Buy	16,997 +16,189	+2,004%	+$2.17M	0.03%	121
2022 Q2	$124K	Sell	808 -310,692	-100%	-$47.7M	﹤0.01%	158
2022 Q1	$50.5M	Buy	311,500 +4,600	+1%	+$746K	0.59%	56
2021 Q4	$41.6M	Buy	306,900 +24,000	+8%	+$3.25M	0.43%	72
2021 Q3	$30.5M	Sell	282,900 -41,300	-13%	-$4.45M	0.31%	89
2021 Q2	$36.5M	Sell	324,200 -59,900	-16%	-$6.75M	0.36%	86
2021 Q1	$41.6M	Buy	384,100 +8,600	+2%	+$931K	0.44%	73
2020 Q4	$40.2M	Buy	375,500 +338,500	+915%	+$36.3M	0.46%	62
2020 Q3	$3.24M	Hold	37,000	–	–	0.04%	134
2020 Q2	$3.63M	Buy	37,000 +11,600	+46%	+$1.14M	0.05%	126
2020 Q1	$1.94M	Sell	25,400 -17,100	-40%	-$1.3M	0.04%	131
2019 Q4	$3.76M	Buy	+42,500	New	+$3.76M	0.06%	116
2019 Q2	–	Hold	0	–	–	–	202
2019 Q1	–	Hold	0	–	–	–	135
2018 Q1	–	Sell	-19,500	Closed	-$1.89M	–	125
2017 Q4	$1.89M	Sell	19,500 -83,277	-81%	-$8.05M	0.2%	82
2017 Q3	$9.13M	Sell	102,777 -11,797	-10%	-$1.05M	0.96%	35
2017 Q2	$8.31M	Buy	114,574 +11,873	+12%	+$861K	0.98%	41
2017 Q1	$6.69M	Buy	102,701 +87,701	+585%	+$5.71M	0.89%	42
2016 Q4	$939K	Hold	15,000	–	–	0.19%	87
2016 Q3	$946K	Hold	15,000	–	–	0.17%	96
2016 Q2	$929K	Hold	15,000	–	–	0.17%	99
2016 Q1	$857K	Buy	+15,000	New	+$857K	0.16%	98